Analyst
BTS Capital
Equibles does not estimate personal net worth.
Harshal Parekh is recorded as Analyst at BTS Capital. Harshal Parekh has spoken on 1 earnings call across 1 company, most recently for Hikal Limited on November 3, 2026. The companies whose calls Harshal Parekh spoke on are classified in the Healthcare sector.
“My question is specifically related to Pharma segment. So if I look at the long-term EBIT margin trajectory in Pharma, we used to make around 14-15% EBIT till FY22.”
BTS Capital
Analyst
Transcript header (unverified)
Hikal Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Hikal Limited
